Prof. dr. Rutten-van Mölken, M.P.M.H.

Maureen Rutten-van Mölken is professor of Economic Evaluation of Innovations for Health at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam, where she is the head of the Health Technology Assessment department. She is also scientific director of the Institute for Medical Technology Assessment (IMTA). 

She teaches “Health Technology Assessment” and “Pharmaceutical Pricing and Market Access” in the Master-program Health Economics Policy and Law at Erasmus University Rotterdam and in the European Master in Health Economics and Management.

Academic Background

Her expertise includes economic evaluation studies, either alongside clinical trials or using probabilistic decision analytic modeling, and outcomes research. She worked in many disease areas, including respiratory diseases (COPD, asthma), rheumatology, diabetes, cardiovascular disease, and Pompe disease. She has a special interest in the cost-effectiveness, and the financing and payment of complex multi-faceted interventions that involve system-level changes like integrated care programs, disease management programs, hospital at home programs, outpatient rehabilitation programs, remote monitoring etc. She also has an interest in the health economics of personalized medicine.

She has almost 30 years of experience in HTA and has been leading many applied economic evaluations and HTA methods-studies leading to high level publications. She is the coordinator of SELFIE, a Horizon2020 project on integrated care in multi-morbidity, and an investigator in Horizon2020 project HEcoPerMed that develops guidance on health economic modelling, and financing and payment strategies, for personalised medicine and applies this guidance to various personalised interventions.

She was trained as a health scientist and health economist and had additional training in epidemiology. She obtained an MSc in health care policy and management at Maastricht University (1988), and a PhD in health economics, also at Maastricht University (1994). She joint iMTA as a senior researcher in 1996. Before, she was an assistant professor in Health Economics and Medical Technology Assessment at the Department of Health Economics of the University of Maastricht.

Experience

• 2022 – present 
  Head of the Health Technology Assessment (HTA) department of the Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam (EUR)
• 2019 – present
  Full Professor of Economic Evaluation of Innovations for Health, ESHPM, EUR
• 2011 – 2018
  Professor of Economic Evaluations of Innovative Health Care for Chronic Diseases, ESHPM. EUR (Professor by special appointment)
• 2006 – present
  Scientific Director of the Institute for Medical Technology Assessment (iMTA) Ltd (± 15 staff members)
• 2005 – 2011
  Associate Professor Health Economics at the Institute for Health Policy and Management (iBMG), Erasmus University Rotterdam
• 1998 – 2021
  Staff member of the management team of the HTA department of iBMG
• 1996 – 2005
  Senior researcher and program coordinator, iBMG/iMTA, Erasmus University Rotterdam
• 1994
  Doctor of Philosophy Degree at the University of Maastricht; Title of thesis: “Costs and Effects of Pharmacotherapy in Asthma and COPD”; promotor: Prof.dr. F.F.H. Rutten, co-promotor: Prof.dr. E.K.A. van Doorslaer
• 1991 – 1996
  Assistant professor at the department Economics of Health Care, University of Maastricht
• 1987 – 1988
  Student Assistant, University of Maastricht, Member of the Educational Committee of the faculty of Health Sciences

Published books

Handbook of Integrated Care by Amelung V, Stein V, Goodwin N, Balicer R, Nolte E, Suter E (Eds), Springer 2017, page 297-314 Tsiachristas A. Rutten van Molken MPMH. Evaluating complex interventions. 
https://link.springer.com/book/10.1007/978-3-319-56103-5

Handbook of Integrated Care by Amelung V, Stein V, Goodwin N, Balicer R, Nolte E, Suter E (Eds), Springer 2017, 315-332 Tsiachristas A. Rutten van Molken MPMH. Economic evaluation of integrated care.
https://link.springer.com/book/10.1007/978-3-319-56103-5

Rutten-van Mölken MPMH, Uyl-de Groot C, Rutten FFH. (eds.) Van kosten tot effecten. Een handleiding voor economische evaluatiestudies in de gezondheidszorg. Tweede, herziene druk, Elsevier, Amsterdam 2010
https://www.bol.com/nl/nl/f/van-kosten-tot-effecten-druk-1/34455899/

Media coverage

Value Insider podcast

Rutten-van Mölken MPMH, Hartgers-Gubbels ES, Chambers M. Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]. International Journal of General Medicine 2022; 15: 8055–8061
https://www.boehringer-ingelheim.com/podcasts/value-insider/